Four novel and two recurrent NHLRC1 (EPM2B) and EPM2A gene mutations leading to Lafora disease in six Turkish families
dc.contributor.author | Salar, Seda | |
dc.contributor.author | Yeni, Naz | |
dc.contributor.author | Gunduz, Aysegul | |
dc.contributor.author | Guler, Ayse | |
dc.contributor.author | Gokcay, Ahmet | |
dc.contributor.author | Velioglu, Sibel | |
dc.contributor.author | Gundogdu, Asli | |
dc.contributor.author | Caglayan, S. Hande | |
dc.date.accessioned | 2019-10-27T21:44:33Z | |
dc.date.available | 2019-10-27T21:44:33Z | |
dc.date.issued | 2012 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Lafora disease (LD) is a type of autosomal recessive, progressive myoclonus epilepsy resulting mostly from mutations in the EPM2A and NHLRC1 genes. Mutational analysis in both genes was initiated with the aim of establishing LD DNA diagnosis in Turkey. Four novel NHLRC1 (p.G131X, p.P69S and p.D82H) and EPM2A (p.V7A) and two recurrent NHLRC1 (p.D146N) and EPM2A (p.R241X) mutations were identified in six families. The delineation of causative mutations in patients provided early disease diagnosis for other family members and contributed to the knowledge of LD pathogenesis. (C) 2011 Elsevier B.V. All rights reserved. | en_US |
dc.description.sponsorship | Bogazici UniversityBogazici University [07HB101]; TUBITAK (Turkish Scientific and Technological Research Council)Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK) | en_US |
dc.description.sponsorship | This study was financially supported by Bogazici University Research Fund Project Number 07HB101. SS was a recipient of TUBITAK (Turkish Scientific and Technological Research Council) graduate scholarship. | en_US |
dc.identifier.doi | 10.1016/j.eplepsyres.2011.09.020 | en_US |
dc.identifier.endpage | 276 | en_US |
dc.identifier.issn | 0920-1211 | |
dc.identifier.issue | 02.Mar | en_US |
dc.identifier.pmid | 22047982 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 273 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.eplepsyres.2011.09.020 | |
dc.identifier.uri | https://hdl.handle.net/11454/47261 | |
dc.identifier.volume | 98 | en_US |
dc.identifier.wos | WOS:000301316200027 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science Bv | en_US |
dc.relation.ispartof | Epilepsy Research | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Lafora disease | en_US |
dc.subject | Mutations | en_US |
dc.subject | EPM2A | en_US |
dc.subject | NHLRC1 (EPM2B) | en_US |
dc.subject | Malin | en_US |
dc.subject | Laforin | en_US |
dc.title | Four novel and two recurrent NHLRC1 (EPM2B) and EPM2A gene mutations leading to Lafora disease in six Turkish families | en_US |
dc.type | Article | en_US |